New Medical Robot for Blood Vessel Procedures Enters Market
Translated & summarized from Al-Shams by baba
A new medical robot system called LIBERTY, designed for remote control of instruments during blood vessel procedures, has received Ministry of Health approval and is set for distribution in the fourth quarter of this year. The system, already launched in the U.S. after FDA authorization, aims to enhance precision and reduce physician exposure to radiation and physical strain. This market is the first outside the U.S. to grant marketing authorization, supporting the company's global expansion strategy.
The story in 5 lines · by baba
- The LIBERTY medical robot system, for remote control of instruments in blood vessels, received Ministry of Health approval.
- The system is expected to see its first distributor orders within the fourth quarter of this year.
- LIBERTY aims to improve precision in vascular procedures and reduce physician radiation exposure and physical strain.
- The robot system has already received FDA authorization and undergone limited and full launches in the U.S.
- This market is the first outside the U.S. to grant marketing authorization for the LIBERTY system.
A new medical robot system, LIBERTY, designed for remote control of instruments during procedures within blood vessels, has received necessary approvals from the Ministry of Health and was registered in the medical devices registry in May 2026. The company anticipates the first orders from distributors within the fourth quarter of this year. This system aims to assist physicians in performing precise interventions while reducing their exposure to radiation and physical strain. The LIBERTY system is intended for single use and is applied in peripheral vascular procedures. It has also obtained authorization from the U.S. Food and Drug Administration (FDA). The company initiated a limited launch in the United States late last year, followed by a full launch in April. Several hospitals across multiple U.S. states have already adopted the system, with the company reporting that its revenues and customer numbers in the second quarter doubled compared to the first quarter. This market represents the first outside the U.S. where the system has secured marketing authorization, aligning with the company's international expansion strategy through collaborations with distributors in developed markets. The company stated that this approval also enables them to obtain a free sale certificate, which can be used to support device registration applications in other countries, potentially facilitating further market expansion. The system is expected to gradually reach hospitals and medical teams following the commencement of distribution and the arrival of initial orders, paving the way for the use of robotics and remote control technologies in specialized vascular procedures.